Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Clinical trial NCT00903110 · RECRUITING
Trial details
- NCT number
- NCT00903110
- Sponsor
- Esteve Pharmaceuticals, S.A.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2008-12-09
- Primary completion
- 2027-12-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.